p73 Antibody
Cat# MBS8583794-0,1mL-HRP
Size : 0.1mL(HRP)
Brand : MyBiosource
p73 Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8583794MBS8583794 is an antibody targeting p73. Also known as p73 Antibody. Reactive in Human, Mouse, Rat, Chicken, Dog, Monkey. Host: Rabbit. Rabbit polyclonal antibody to p73 More details
Product Overview
Online Datasheet in PDFProduct Name
p73, Polyclonal Antibody
Full Product Name
p73 Antibody
Product Gene Name
anti-p73 antibody
Product Synonym Gene Name
TP73
Product Synonym Names
P73; Tumor protein p73; p53-like transcription factor; p53-related protein
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Chicken, Dog, Monkey
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of p73 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
69,623 Da
Chromosome Location
Chromosome: 1; NC_000001.10 (3569129..3652765). Location: 1p36.3
OMIM
601990
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human p73. The exact sequence is proprietary.
Product Categories/Family for anti-p73 antibody
Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-p73 antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-p73 antibody
WB: 1:500-1:1000
IHC: 1:50-1:200
IHC: 1:50-1:200
Other Notes
Small volumes of anti-p73 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for p73. It may not necessarily be applicable to this product.
NCBI Official Full Name
tumor protein p73 isoform b
NCBI Official Synonym Full Names
tumor protein p73
NCBI Official Symbol
TP73
NCBI Official Synonym Symbols
P73
UniProt Protein Name
Tumor protein p73
UniProt Synonym Protein Names
p53-like transcription factor; p53-related protein
Protein Family
Peroxidase
UniProt Gene Name
TP73
UniProt Synonym Gene Names
P73
UniProt Entry Name
P73_HUMAN
NCBI Protein Information
tumor protein p73; p53-related protein; p53-like transcription factor
NCBI Summary for p73
This gene encodes a member of the p53 family of transcription factors involved in cellular responses to stress and development. It maps to a region on chromosome 1p36 that is frequently deleted in neuroblastoma and other tumors, and thought to contain multiple tumor suppressor genes. The demonstration that this gene is monoallelically expressed (likely from the maternal allele), supports the notion that it is a candidate gene for neuroblastoma. Many transcript variants resulting from alternative splicing and/or use of alternate promoters have been found for this gene, but the biological validity and the full-length nature of some variants have not been determined. [provided by RefSeq, Feb 2011]
Show more UniProt Comments for p73
p73: a protein of the p53 family of proteins. p73, like p53, may have tumor suppressor activity, but its multiple isoforms possess different and sometimes opposing functions. Participates in the apoptotic response to DNA damage. Phosphorylated in a cell cycle-dependent manner and negatively regulated by CDKs. When overproduced, activates transcription from p53-responsive promoters and induces apoptosis. Nine transactivation competent (TA) or dominant negative (DN) isoforms, derived from alternative-splicing and alternative promoters, have been described. NH2-terminally truncated p73 isoforms (DNp73) may be oncogenic. DNp73 is elevated in a number of cancers and is associated with adverse clinical outcomes and resistance to chemotherapy. The C-terminal oligomerization domain binds to the ABL1 tyrosine kinase SH3 domain. Isoform Beta interacts homotypically and with p53/TP53, whereas isoform Alpha does not. Isoform Gamma interacts homotypically and with all p73 isoforms. Isoform Delta interacts with isoform Gamma, isoform Alpha, and homotypically. Isoforms Alpha and Beta interact with HIPK2. Isoform Alpha interacts with RANBP9; forms complex with p53 and CABLES1. Isoform Beta interacts with WWOX; interacts with HECW2.
Protein type: Tumor suppressor; DNA-binding; Transcription factor
Chromosomal Location of Human Ortholog: 1p36.3
Cellular Component: nucleoplasm; Golgi apparatus; transcription factor complex; intracellular membrane-bound organelle; cell junction; chromatin; cytosol; nucleus
Molecular Function: identical protein binding; protein binding; p53 binding; metal ion binding; double-stranded DNA binding; damaged DNA binding; chromatin binding; transcription factor activity; transcription factor binding; protein kinase binding
Biological Process: transcription from RNA polymerase II promoter; G1 DNA damage checkpoint; cerebrospinal fluid secretion; positive regulation of cell size; activation of MAPK activity; positive regulation of transcription, DNA-dependent; regulation of mitotic cell cycle; negative regulation of transcription from RNA polymerase II promoter; post-embryonic development; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; negative regulation of cardiac muscle cell proliferation; response to gamma radiation; positive regulation of oligodendrocyte differentiation; negative regulation of neuron apoptosis; cell cycle arrest; kidney development; inflammatory response; DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; protein tetramerization; response to X-ray; negative regulation of JNK activity; release of cytochrome c from mitochondria; mismatch repair; hippocampus development; digestive tract morphogenesis; response to organic nitrogen; negative regulation of neuron differentiation; DNA damage response, signal transduction resulting in induction of apoptosis; regulation of gene expression; neuron development; positive regulation of transcription from RNA polymerase II promoter; response to DNA damage stimulus
Show more Protein type: Tumor suppressor; DNA-binding; Transcription factor
Chromosomal Location of Human Ortholog: 1p36.3
Cellular Component: nucleoplasm; Golgi apparatus; transcription factor complex; intracellular membrane-bound organelle; cell junction; chromatin; cytosol; nucleus
Molecular Function: identical protein binding; protein binding; p53 binding; metal ion binding; double-stranded DNA binding; damaged DNA binding; chromatin binding; transcription factor activity; transcription factor binding; protein kinase binding
Biological Process: transcription from RNA polymerase II promoter; G1 DNA damage checkpoint; cerebrospinal fluid secretion; positive regulation of cell size; activation of MAPK activity; positive regulation of transcription, DNA-dependent; regulation of mitotic cell cycle; negative regulation of transcription from RNA polymerase II promoter; post-embryonic development; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; negative regulation of cardiac muscle cell proliferation; response to gamma radiation; positive regulation of oligodendrocyte differentiation; negative regulation of neuron apoptosis; cell cycle arrest; kidney development; inflammatory response; DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; protein tetramerization; response to X-ray; negative regulation of JNK activity; release of cytochrome c from mitochondria; mismatch repair; hippocampus development; digestive tract morphogenesis; response to organic nitrogen; negative regulation of neuron differentiation; DNA damage response, signal transduction resulting in induction of apoptosis; regulation of gene expression; neuron development; positive regulation of transcription from RNA polymerase II promoter; response to DNA damage stimulus
Research Articles on p73
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-p73 antibody
| Reference Product | PubMed Publications |
|---|---|
| TP63 antibody | >15 publications with p73 and TP63 |
| MDM2 antibody | >4 publications with p73 and MDM2 |
| MYC antibody | >4 publications with p73 and MYC |
| CDKN1A antibody | >4 publications with p73 and CDKN1A |
| WT1 antibody | >3 publications with p73 and WT1 |
| HRAS antibody | >2 publications with p73 and HRAS |
| BAX antibody | >2 publications with p73 and BAX |
| MAPK8 antibody | >1 publications with p73 and MAPK8 |
| HIPK2 antibody | >1 publications with p73 and HIPK2 |
| CDK2 antibody | >1 publications with p73 and CDK2 |
Pathways associated with anti-p73 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Alpha6-Beta4 Integrin Signaling Pathway antibodies | Alpha6-Beta4 Integrin Signaling Pathway Diagram |
| Apoptosis Pathway antibodies | Apoptosis Pathway Diagram |
| DNA Damage Response (only ATM Dependent) Pathway antibodies | DNA Damage Response (only ATM Dependent) Pathway Diagram |
| Direct P53 Effectors Pathway antibodies | Direct P53 Effectors Pathway Diagram |
| E2F Transcription Factor Network Pathway antibodies | E2F Transcription Factor Network Pathway Diagram |
| Hippo Signaling Pathway antibodies | Hippo Signaling Pathway Diagram |
| Hippo Signaling Pathway antibodies | Hippo Signaling Pathway Diagram |
| Measles Pathway antibodies | Measles Pathway Diagram |
| Measles Pathway antibodies | Measles Pathway Diagram |
| Neurotrophin Signaling Pathway antibodies | Neurotrophin Signaling Pathway Diagram |
Diseases associated with anti-p73 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >106 publications with p73 and Neoplasms |
| Carcinoma Antibodies | >44 publications with p73 and Carcinoma |
| Neoplasms, Experimental Antibodies | >15 publications with p73 and Neoplasms, Experimental |
| Colorectal Neoplasms Antibodies | >13 publications with p73 and Colorectal Neoplasms |
| Head and Neck Neoplasms Antibodies | >12 publications with p73 and Head and Neck Neoplasms |
| Carcinoma, Squamous Cell Antibodies | >12 publications with p73 and Carcinoma, Squamous Cell |
| Cell Transformation, Neoplastic Antibodies | >11 publications with p73 and Cell Transformation, Neoplastic |
| Breast Neoplasms Antibodies | >11 publications with p73 and Breast Neoplasms |
| Glioma Antibodies | >10 publications with p73 and Glioma |
| Neuroblastoma Antibodies | >9 publications with p73 and Neuroblastoma |
Organs/Tissues associated with anti-p73 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Brain Antibodies | >13 publications with p73 and Brain |
| Lung Antibodies | >8 publications with p73 and Lung |
| Liver Antibodies | >8 publications with p73 and Liver |
| Prostate Antibodies | >5 publications with p73 and Prostate |
| Lymph Node Antibodies | >5 publications with p73 and Lymph Node |
| Embryonic Tissue Antibodies | >5 publications with p73 and Embryonic Tissue |
| Placenta Antibodies | >2 publications with p73 and Placenta |
| Eye Antibodies | >1 publications with p73 and Eye |
| Intestine Antibodies | >1 publications with p73 and Intestine |
| Uterus Antibodies | >1 publications with p73 and Uterus |


